SARS-CoV-2: vaccinology and emerging therapeutics; challenges and future developments

As SARS-CoV-2 emerge, variants such as Omicron (B.1.1.529), Delta (B.1.617.2), and those from the United Kingdom (B.1.1.7), South Africa (B.1.351), Brazil (P.1) and India (B.1.6.17 lineage) have raised concerns of the reduced neutralising ability of antibodies and increased ability to evade the curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Adesokan, Adedapo, Obeid, Mohammad A., Lawal, Aisha F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Newlands Press Ltd 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884156/
https://www.ncbi.nlm.nih.gov/pubmed/35195017
http://dx.doi.org/10.4155/tde-2021-0075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884156/
https://www.ncbi.nlm.nih.gov/pubmed/35195017
http://dx.doi.org/10.4155/tde-2021-0075

Ejemplares similares